Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Wockhardt | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: Wockhardt

Earnings drop 70% as three India plants face export restrictions

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Wockhardt
 
2Q Revenues: 12.0 billion rupees (-11%)

2Q Earnings: 1.4 billion rupees (-70%)

YTD Revenues: 26.0 billion rupees (-5%)

YTD Earnings: 4.6 billion rupees (-44%)

Comments: Results were impacted by restrictions on shipping medicines to the U.S. and UK from one of its factories after health regulators identified deficiencies at the plant. The UK’s MHRA recently added restrictions on exports from two other factories. According to a Wockhardt statement, the U.S. import alert, reported in May, could cost about $100 million in annual sales. It has subsequently taken measures to improve quality oversight at its factories, including the appointment of a new quality chief and hiring of outside consultants.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters